• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Regard Secures $61M for AI-Powered Clinical Insights Platform

by Fred Pennic 07/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
WakeMed to Deploy Regard’s AI Clinical Automation Platform Across Enterprise

What You Should Know: 

– Regard, an AI-powered clinical insights platform raises $61M in Series B funding led by Oak HC/FT with participation from prominent healthcare and technology investors. 

– The investment will fuel the company’s mission to unlock the full potential of patient data for improved clinical care.

Untapped Potential in Healthcare Data

The healthcare industry is experiencing a data deluge. New technologies generate mountains of patient information, but a vast majority remains unutilized for clinical decision-making. According to The World Economic Forum, physicians leverage less than 3% of the data available to them. With an average of 50,000 data points per patient, the gap between raw data and actionable insights is significant.

Regard: Bridging the Gap with AI

Regard steps into this gap by acting as an intelligent data bridge. The platform analyzes all available patient data and generates insights, including potential diagnoses. Clinicians then review and approve these recommendations, enabling them to deliver more informed and efficient care. Regard further streamlines workflows by ensuring complete and accurate documentation in a standardized format, a key factor for both clinical quality and hospital revenue.

Expansion Plans

Since its launch in 2021, Regard’s AI technology has identified over three million diagnoses and generated more than $50M in additional revenue for healthcare system partners like Banner Health and Sentara. The company recently announced a new partnership with WakeMed Health & Hospitals, a leading North Carolina health system.

The $61M funding will propel Regard’s growth on several fronts:

  • Accelerated Product Development: Enhancements to the core clinical insights platform will further empower clinicians.
  • Large Language Model Research: Investment in LLM research holds promise for even more advanced data analysis and insights generation.
  • Beyond Inpatient Facilities: Regard plans to expand its reach beyond traditional hospital settings.

“Imagine a doctor having all the EHR information they need about a patient, right in front of them, in just seconds. Regard is augmenting patient care by analyzing overwhelming mountains of clinical data and providing clinicians with potential diagnoses and treatment recommendations, impacting the quality and safety of care in real-time,” said Eli Ben-Joseph, CEO at Regard. “That’s a game-changer – not just for doctors, but for the people whose lives are in their hands.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Revenue Cycle Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |